Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Lamivudine 300mg vs 150mg in Healthy Volunteers
NCT00985647Phase 2Completed
- Sponsor
- The Kirby Institute
- Start
- Dec 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lamivudine in human immunodeficiency virus infection (HIV), sponsored by The Kirby Institute. Started Dec 2009; status: completed.
02
Drugs
lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00985647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985647.